Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide on Weight Loss in Patients With Overweight or Obesity Without Diabetes Mellitus-A Systematic Review and Meta-Analysis of Randomized Controlled Trials

CTSA https://pubmed.ncbi.nlm.nih.gov/38923272/ 2024-06-23T00:00:00Z Obesity Reviews